The Health Sciences Authority HSA announced on Thursday that Pfizer's Comirnaty COVID 19 vaccine has been approved for children aged six months through four years. The vaccine regimen for the primary series in this age group consists of three 3 microgram doses over at least 11 weeks.
The first two doses should be administered three weeks apart, followed by a third dose to be administered at least eight weeks after the second dose.
The Expert Committee on COVID 19 vaccine and the Ministry of Health MOH said that there will be official recommendations on the use of this vaccine.
The agency said the benefits outweighed the risks for the use of Comirnaty in children aged six months through four years and that the benefits outweighed the risks for the use of Comirnaty in children aged six months.
In making the regulatory decision, HSA consulted experts from its Medicines Advisory Committee and Panel of Infectious Diseases Experts, it added.
Singapore has authorised the use of a second vaccine in young children. The first, Moderna's two-dose Spikevax COVID 19 vaccine, was approved in August for use in children aged six months up to five years.
The Moderna vaccine in 25 microgram doses will be available next month, and the Pfizer shot is expected to be available by the end of the year, MOH said.
Vaccinations and boosters are a part of our strategy to make sure our children are well protected against severe illness, should they be infected with COVID - 19, said MOH.
We encourage everyone who is eligible to be vaccinated when it is offered to them.